Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens

Susan M. Jones, L. D. Snell, K. M. Johnson

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

The effects of phencyclidine (PCP) on the release of acetylcholine and dopamine, stimulated by excitatory amino acid agonists was examined in slices of nucleus accumbens of the rat. In slices incubated in [3H]choline or [3H]dopamine, the amount of tritium efflux produced by 1 mM N-methyl-D-aspartate (NMDA), kainic acid (KA) or quisqualic acid (QA) was compared with that produced in the presence of varying concentrations of phencyclidine. N-Methyl-D-aspartate stimulated the calcium-dependent release of both ACh and DA, which was completely inhibited by physiological concentrations of magnesium and inhibited by 2-aminophosphonovalerate (2-APV). Kainic acid- and quisqualic acid-stimulated release of ACh and DA was partially inhibited by magnesium or by 2-APV. Phencyclidine inhibited NMDA-stimulated release of ACh and DA with IC50's around 100 nM. Phencyclidine (0.1 μM) also significantly inhibited kainic acid and quisqualic acid-induced release of ACh in magnesium-free but not magnesium-containing buffer, suggesting that the effect of PCP on kainic acid- and possibly quisqualic acid-stimulated release of ACh is on that part of the response which is mediated by NMDA receptors. The results suggest that the inhibition by PCP of the release of ACh and DA in the nucleus accumbens is selective for NMDA-type receptors.

Original languageEnglish (US)
Pages (from-to)173-179
Number of pages7
JournalNeuropharmacology
Volume26
Issue number2-3
DOIs
StatePublished - 1987

Fingerprint

Quisqualic Acid
Phencyclidine
Excitatory Amino Acids
Kainic Acid
Nucleus Accumbens
Magnesium
Neurotransmitter Agents
N-Methylaspartate
N-Methyl-D-Aspartate Receptors
Dopamine
Excitatory Amino Acid Agonists
Tritium
Choline
Inhibitory Concentration 50
Acetylcholine
Buffers
Calcium

Keywords

  • acetylcholine release
  • dopamine release
  • excitatory amino acids
  • N-methyl-D-aspartate
  • nucleus accumbens
  • phencyclidine

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens. / Jones, Susan M.; Snell, L. D.; Johnson, K. M.

In: Neuropharmacology, Vol. 26, No. 2-3, 1987, p. 173-179.

Research output: Contribution to journalArticle

Jones, Susan M. ; Snell, L. D. ; Johnson, K. M. / Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens. In: Neuropharmacology. 1987 ; Vol. 26, No. 2-3. pp. 173-179.
@article{71c47dfba50040109b10720726beec4b,
title = "Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens",
abstract = "The effects of phencyclidine (PCP) on the release of acetylcholine and dopamine, stimulated by excitatory amino acid agonists was examined in slices of nucleus accumbens of the rat. In slices incubated in [3H]choline or [3H]dopamine, the amount of tritium efflux produced by 1 mM N-methyl-D-aspartate (NMDA), kainic acid (KA) or quisqualic acid (QA) was compared with that produced in the presence of varying concentrations of phencyclidine. N-Methyl-D-aspartate stimulated the calcium-dependent release of both ACh and DA, which was completely inhibited by physiological concentrations of magnesium and inhibited by 2-aminophosphonovalerate (2-APV). Kainic acid- and quisqualic acid-stimulated release of ACh and DA was partially inhibited by magnesium or by 2-APV. Phencyclidine inhibited NMDA-stimulated release of ACh and DA with IC50's around 100 nM. Phencyclidine (0.1 μM) also significantly inhibited kainic acid and quisqualic acid-induced release of ACh in magnesium-free but not magnesium-containing buffer, suggesting that the effect of PCP on kainic acid- and possibly quisqualic acid-stimulated release of ACh is on that part of the response which is mediated by NMDA receptors. The results suggest that the inhibition by PCP of the release of ACh and DA in the nucleus accumbens is selective for NMDA-type receptors.",
keywords = "acetylcholine release, dopamine release, excitatory amino acids, N-methyl-D-aspartate, nucleus accumbens, phencyclidine",
author = "Jones, {Susan M.} and Snell, {L. D.} and Johnson, {K. M.}",
year = "1987",
doi = "10.1016/0028-3908(87)90206-1",
language = "English (US)",
volume = "26",
pages = "173--179",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "2-3",

}

TY - JOUR

T1 - Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens

AU - Jones, Susan M.

AU - Snell, L. D.

AU - Johnson, K. M.

PY - 1987

Y1 - 1987

N2 - The effects of phencyclidine (PCP) on the release of acetylcholine and dopamine, stimulated by excitatory amino acid agonists was examined in slices of nucleus accumbens of the rat. In slices incubated in [3H]choline or [3H]dopamine, the amount of tritium efflux produced by 1 mM N-methyl-D-aspartate (NMDA), kainic acid (KA) or quisqualic acid (QA) was compared with that produced in the presence of varying concentrations of phencyclidine. N-Methyl-D-aspartate stimulated the calcium-dependent release of both ACh and DA, which was completely inhibited by physiological concentrations of magnesium and inhibited by 2-aminophosphonovalerate (2-APV). Kainic acid- and quisqualic acid-stimulated release of ACh and DA was partially inhibited by magnesium or by 2-APV. Phencyclidine inhibited NMDA-stimulated release of ACh and DA with IC50's around 100 nM. Phencyclidine (0.1 μM) also significantly inhibited kainic acid and quisqualic acid-induced release of ACh in magnesium-free but not magnesium-containing buffer, suggesting that the effect of PCP on kainic acid- and possibly quisqualic acid-stimulated release of ACh is on that part of the response which is mediated by NMDA receptors. The results suggest that the inhibition by PCP of the release of ACh and DA in the nucleus accumbens is selective for NMDA-type receptors.

AB - The effects of phencyclidine (PCP) on the release of acetylcholine and dopamine, stimulated by excitatory amino acid agonists was examined in slices of nucleus accumbens of the rat. In slices incubated in [3H]choline or [3H]dopamine, the amount of tritium efflux produced by 1 mM N-methyl-D-aspartate (NMDA), kainic acid (KA) or quisqualic acid (QA) was compared with that produced in the presence of varying concentrations of phencyclidine. N-Methyl-D-aspartate stimulated the calcium-dependent release of both ACh and DA, which was completely inhibited by physiological concentrations of magnesium and inhibited by 2-aminophosphonovalerate (2-APV). Kainic acid- and quisqualic acid-stimulated release of ACh and DA was partially inhibited by magnesium or by 2-APV. Phencyclidine inhibited NMDA-stimulated release of ACh and DA with IC50's around 100 nM. Phencyclidine (0.1 μM) also significantly inhibited kainic acid and quisqualic acid-induced release of ACh in magnesium-free but not magnesium-containing buffer, suggesting that the effect of PCP on kainic acid- and possibly quisqualic acid-stimulated release of ACh is on that part of the response which is mediated by NMDA receptors. The results suggest that the inhibition by PCP of the release of ACh and DA in the nucleus accumbens is selective for NMDA-type receptors.

KW - acetylcholine release

KW - dopamine release

KW - excitatory amino acids

KW - N-methyl-D-aspartate

KW - nucleus accumbens

KW - phencyclidine

UR - http://www.scopus.com/inward/record.url?scp=0023127818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023127818&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(87)90206-1

DO - 10.1016/0028-3908(87)90206-1

M3 - Article

C2 - 2884587

AN - SCOPUS:0023127818

VL - 26

SP - 173

EP - 179

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 2-3

ER -